Suppr超能文献

使用液相色谱-质谱联用技术(LCMS E)鉴定和定量在大肠杆菌中表达的鼠疫耶尔森菌融合蛋白F1-V的Nα-乙酰化形式

Identification and quantification of N alpha-acetylated Y. pestis fusion protein F1-V expressed in Escherichia coli using LCMS E.

作者信息

Bariola Pauline A, Russell Brett A, Monahan Steven J, Stroop Steven D

机构信息

GlaxoSmithKline Biologicals North America, 19204 North Creek Parkway, Bothell, WA 98011, USA.

出版信息

J Biotechnol. 2007 May 31;130(1):11-23. doi: 10.1016/j.jbiotec.2007.02.024. Epub 2007 Mar 3.

Abstract

N-terminal acetylation in E coli is a rare event catalyzed by three known N-acetyl-transferases (NATs), each having a specific ribosomal protein substrate. Multiple, gram-scale lots of recombinant F1-V, a fusion protein constructed from Y. Pestis antigens, were expressed and purified from a single stably transformed E. coli cell bank. A variant form of F1-V with mass increased by 42-43 Da was detected in all purified lots by electrospray orthogonal acceleration time-of-flight mass spectrometry (MS). Peptide mapping LCMS localized the increased mass to an N-terminal Lys-C peptide, residues 1-24, and defined it as +42.0308+/-0.0231 Da using a LockSpray exact mass feature and a leucine enkaphalin mass standard. Sequencing of the variant 1-24 peptide by LCMS and high-energy collision induced dissociation (LCMS(E)) further localized the modification to the amino terminal tri-peptide ADL and identified the modification as N(alpha)-acetylation. The average content of N(alpha)-acetylated F1-V in five lots was 24.7+/-2.6% indicating that a stable acetylation activity for F1-V was established in the E. coli expression system. Alignment of the F1-V N-terminal sequence with those of other known N(alpha)-acetylated ectopic proteins expressed in E. coli reveals a substrate motif analogous to the eukaryote NatA' acetylation pathway and distinct from endogenous E. coli NAT substrates.

摘要

在大肠杆菌中,N 端乙酰化是一种罕见事件,由三种已知的 N - 乙酰转移酶(NATs)催化,每种酶都有特定的核糖体蛋白底物。从单个稳定转化的大肠杆菌细胞库中表达并纯化了多批克级规模的重组 F1 - V,这是一种由鼠疫耶尔森菌抗原构建的融合蛋白。通过电喷雾正交加速飞行时间质谱(MS)在所有纯化批次中检测到一种质量增加了 42 - 43 Da 的 F1 - V 变体形式。肽图谱 LCMS 将质量增加定位到 N 端的 Lys - C 肽(第 1 - 24 位残基),并使用 LockSpray 精确质量特征和亮氨酸脑啡肽质量标准将其定义为 +42.0308±0.0231 Da。通过 LCMS 和高能碰撞诱导解离(LCMS(E))对变体 1 - 24 肽进行测序,进一步将修饰定位到氨基末端三肽 ADL,并确定该修饰为 N(α)-乙酰化。五个批次中 N(α)-乙酰化 F1 - V 的平均含量为 24.7±2.6%,表明在大肠杆菌表达系统中建立了针对 F1 - V 的稳定乙酰化活性。将 F1 - V 的 N 端序列与在大肠杆菌中表达的其他已知 N(α)-乙酰化异位蛋白的序列进行比对,发现一个类似于真核生物 NatA 乙酰化途径且不同于大肠杆菌内源性 NAT 底物的底物基序。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验